Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

June 20, 2020

C-Path’s Transplant Therapeutics Consortium Receives Acceptance of Letter of Intent for iBox Scoring System (Composite Biomarker Panel) as a Reasonably Likely Surrogate Endpoint

Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplan

June 19, 2020

June 14, 2020

June 12, 2020-June 18, 2020

Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.

June 11, 2020

An online case reporting platform has been optimized for COVID-19 and will be the springboard for a new public-private drug

June 5, 2020

Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera

May 14, 2020

May 13, 2020

TUCSON, Ariz., and OLDWICK, N.J. May 13, 2020 — The Critical Path Institute (C-Path) and Provention Bio, Inc. (Nas

May 6, 2020

April 30, 2020

TUCSON, Ariz., April 30, 2020 — Tucson-based Critical Path Institute (C-Path) today announced the appointment of two new